INSULET CORPORATION is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary discreet and easy-to-use insulin infusion system that features two easy-to-use components with no tubing and fully-automated cannula insertion. Through the OmniPod System Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes. Insulet Corp. has a market cap of $331 million; its shares were traded at around $11.86 with and P/S ratio of 9.2.
Insiders' Positions with PODD
- Sell:: Secretary and General Counsel R Anthony Diehl sold 3,000 shares of PODD stock on 10/01/2009 at the average price of 11.1, the price of the stock has increased by 6.85% since
- Sell:: Secretary and General Counsel R Anthony Diehl sold 14,421 shares of PODD stock on 09/10/2009 at the average price of 10, the price of the stock has increased by 18.6% since
Rate This Article: |
  |